Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.

Ther Adv Drug Saf · 2019 · PMC6354302 · PMID 30728944

Europe PMC DOI

hedged sentences

0.2740

closest p · 5.5× alpha

0.2740

boldest claim

The sentences

did not reach statistical significancep = 0.274not close (p > 0.1)

Even though the simvastatin coprescribing rate decreased by a greater magnitude (−0.024%pt.), it did not reach statistical significance level ( p = 0.274).

also in 111,027 other papers

a decreasing trendno p-value reported

The drug most frequently coprescribed with simvastatin, on a decreasing trend (by 0.19 percentage points) was gemfibrozil (in 2013, 2014 and 2015, respectively; 2.9, 2.3 and 2.0% in university hospitals, and 2.5, 2.0 and 1.6% in general hospitals).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.